Control of mitotic exit by PP2A regulation of Cdc25C and Cdk1

Forester, C. M. and Maddox, J. and Louis, J. V. and Goris, J. and Virshup, D. M. (2007) Control of mitotic exit by PP2A regulation of Cdc25C and Cdk1. Proceedings of the National Academy of Sciences, 104 (50). pp. 19867-19872. ISSN 0027-8424

[img]
Preview
PDF
PNAS-2007-Forester-19867-72.pdf

Download (759kB) | Preview
Official URL: http://dx.doi.org/10.1073/pnas.0709879104

Abstract

Inactivation of maturation-promoting factor [(MPF) Cdk1/Cyclin B] is a key event in the exit from mitosis. Although degradation of Cyclin B is important for MPF inactivation, recent studies indicate that Cdk1 phosphorylation and inactivation occur before Cyclin B degradation and, therefore, also may be important steps in the exit from mitosis. Cdk1 activity is controlled by the Cdc25C phosphatase, which is turned on at the G2/M transition to catalyze Cdk1 activation. PP2A:B56� is a negative regulator of Cdc25C during interphase. We show here that PP2A:B56� also regulates Cdc25C at mitosis. Failure of PP2A:B56� to dephosphorylate Cdc25C at mitosis results in prolonged hyperphosphorylation and activation of Cdc25C, causing persistent dephosphorylation and, hence, activation of Cdk1. This constitutive activation of Cdc25C and Cdk1 leads to a delayed exit from mitosis. Consistent with Cdk1 as a major biological target of B56�, stable knockdown and germ-line mouse KO of B56� leads to compensatory transcriptional up-regulation of Wee1 kinase to oppose the Cdc25C activity and permit cell survival. These observations place PP2A:B56� as a key upstream regulator of Cdk1 activity upon exit from mitos

Item Type: Article
Subjects: Pharmaceutical Sciences
Divisions: College of Pharmacy > Pharmaceutical Sciences
Depositing User: Dr Justin Louis
Date Deposited: 14 Jun 2017 10:51
Last Modified: 14 Jun 2017 10:51
URI: http://eprints.kku.edu.sa/id/eprint/761

Actions (login required)

View Item View Item